QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ogino, S. Articles by Nomura, Y. Search for Related Content PubMed PubMed Citation Articles by Ogino, S. Articles by Nomura, Y.

Herbimycin A Abrogates Nuclear Factor-B Activation by Interacting Preferentially with the IB Kinase Subunit

Department of Pharmacology, Graduate School of Pharmaceutical Sciences, Hokkaido University, Sapporo, Japan

NF (nuclear factor)-B is known to be a critical transcription factor in inflammatory responses. We have reported that herbimycin A, a potent Src tyrosine kinase inhibitor, attenuates the NF-B activation triggered by cytokines, bacterial endotoxin, and hydrogen peroxide. Accompanying the suppression by this agent, NF-B-dependent gene expressions, such as cytokine, chemokine, and inducible-type nitric oxide, are specifically inhibited in glial cells. In the present study, we attempted to elucidate the possible target protein for herbimycin A on this pathway. We demonstrate here that herbimycin A preferentially inhibits IKK (IB kinase). Furthermore, substituting alanine for the cysteine at 59 (Cys59) in IKK resulted in the insensitivity to herbimycin A, suggesting that this compound may interact with the Cys59 residue located near the catalytic ATP binding site. Taken together, these results indicate that herbimycin A can be considered a novel candidate for an anti-inflammatory drug agent through its specific inhibition of IKK, which results in prevention of the expression of NF-B-dependent genes implicated in the pathogenesis of inflammatory responses.

Address correspondence to: Prof. Yasuyuki Nomura, Department of Pharmacology, Graduate School of Pharmaceutical Sciences, Hokkaido University, Sapporo 060-0812, Japan. E-mail: nomura{at}pharm.hokudai.ac.jp

This article has been cited by other articles:

				M. K. Pandey, B. Sung, A. B. Kunnumakkara, G. Sethi, M. M. Chaturvedi, and B. B. Aggarwal Berberine Modifies Cysteine 179 of I{kappa}B{alpha} Kinase, Suppresses Nuclear Factor-{kappa}B-Regulated Antiapoptotic Gene Products, and Potentiates Apoptosis Cancer Res., July 1, 2008; 68(13): 5370 - 5379. [Abstract] [Full Text] [PDF]

				S.-S. Yan, Y. Li, Y. Wang, S.-S. Shen, Y. Gu, H.-B. Wang, G.-W. Qin, and Q. Yu 17-Acetoxyjolkinolide B irreversibly inhibits I{kappa}B kinase and induces apoptosis of tumor cells Mol. Cancer Ther., June 1, 2008; 7(6): 1523 - 1532. [Abstract] [Full Text] [PDF]

				Q. Hao, S. A. Rutherford, B. Low, and H. Tang Suppression of the Phosphorylation of Receptor Tyrosine Phosphatase-{alpha} on the Src-Independent Site Tyrosine 789 by Reactive Oxygen Species Mol. Pharmacol., June 1, 2006; 69(6): 1938 - 1944. [Abstract] [Full Text] [PDF]

				K. Tsuruma, T. Nakagawa, N. Morimoto, M. Minami, H. Hara, T. Uehara, and Y. Nomura Glucocorticoid Modulatory Element-binding Protein 1 Binds to Initiator Procaspases and Inhibits Ischemia-induced Apoptosis and Neuronal Injury J. Biol. Chem., April 21, 2006; 281(16): 11397 - 11404. [Abstract] [Full Text] [PDF]

				M. B. Gill, J.-E. Murphy, and J. D. Fingeroth Functional Divergence of Kaposi's Sarcoma-Associated Herpesvirus and Related Gamma-2 Herpesvirus Thymidine Kinases: Novel Cytoplasmic Phosphoproteins That Alter Cellular Morphology and Disrupt Adhesion J. Virol., December 1, 2005; 79(23): 14647 - 14659. [Abstract] [Full Text] [PDF]